Extension of NPDE for evaluation of nonlinear mixed effect models in presence of data below the quantification limit with applications to HIV dynamic model-Reference-Cited by-同舟云学术

Extension of NPDE for evaluation of nonlinear mixed effect models in presence of data below the quantification limit with applications to HIV dynamic model

Published:2012-08-11 Issue:5 Volume:39 Page:499-518
ISSN:1567-567X
Container-title:Journal of Pharmacokinetics and Pharmacodynamics
language:en
Short-container-title:J Pharmacokinet Pharmacodyn

Author:

Nguyen Thi Huyen Tram,Comets Emmanuelle,Mentré France

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s10928-012-9264-2.pdf

Reference30 articles.

1. Sheiner LB, Rosenberg B, Melmon KL (1972) Modelling of individual pharmacokinetics for computer-aided drug dosage. Comput Biomed Res 5:441–459

2. Sheiner LB, Rosenberg B, Marathe VV (1977) Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm 5:445–479

3. Hughes JP (1999) Mixed effects models with censored data with application to HIV RNA levels. Biometrics 55:9–625

4. Jacqmin-Gadda H, Thiebaut R, Chene G, Commenges D (2000) Analysis of left-censored longitudinal data with application to viral load in HIV infection. Biostatistics 1:68–355

5. Perelson AS, Ribeiro RM (2008) Estimating drug efficacy and viral dynamic parameters: HIV and HCV. Stat Med 27:57–4647

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does Sample Size, Sampling Strategy, or Handling of Concentrations Below the Lower Limit of Quantification Matter When Externally Evaluating Population Pharmacokinetic Models?;European Journal of Drug Metabolism and Pharmacokinetics;2024-05-05

2. Does Sample Size, Sampling Strategy, or Handling of Concentrations Below the Lower Limit of Quantification Matter When Externally Evaluating Population Pharmacokinetic Models?;2023

3. What to Do About Missed Doses? A Retrospective Study of Olanzapine in the Elderly;Drug Design, Development and Therapy;2021-08

4. Developing Tools to Evaluate Non-linear Mixed Effect Models: 20 Years on the npde Adventure;The AAPS Journal;2021-05-19

5. Population Pharmacokinetic Model of Oxfendazole and Metabolites in Healthy Adults following Single Ascending Doses;Antimicrobial Agents and Chemotherapy;2021-03-18